Axsome Therapeutics (AXSM) Misses Q1 EPS by 93c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
• Champions Oncology (CSBR) Tops Q1 EPS by 6c